James Kovach, MD, JD, serves as Vice President of Business Development for CrowdOptic, a venture-backed company using real-time sensor data from electronic devices and its own patented CrowdOptic algorithms to identify and track where devices are aimed (focus) and to identify groups of people with the same focus (clusters).
CrowdOptic technology, which includes sensor data smoothing, EXIF data mining and focal analytics, is instantly deployable in a range of mobile applications and technology environments to enhance broadcasting, security, social media sharing and advertising.
Dr. Kovach is also founder of Beneufit, a start-up company providing a personalized exercise system for people fighting chronic disease, tapping into the body’s natural ability to self-heal through exercise. He received his medical degree with distinction from the University of Kentucky while simultaneously playing in the National Football League. Following his NFL career, he attended law school at Stanford University and practiced corporate law in Palo Alto, California.
Dr. Kovach has served as Chief Operating Officer of Athersys, Inc., a leading public biotechnology company developing stem cell therapeutics. Two stem cell products initiated under his tenure now are in Phase II clinical development for inflammatory bowel disease and ischemic stroke. He has also served as President of the Buck Institute for Age Research. Named by NIH as a national center of excellence, the Buck Institute is an independent research institute dedicated exclusively to research on aging and age-associated disease. Dr. Kovach also served as a member of the NFL Head, Neck and Spine Committee.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.